Ginkgo Bioworks, Inductive Bio and Tangible Launch ADME-One
BOSTON, Massachusetts, May 26, 2026 Ginkgo Bioworks, through its Ginkgo Datapoints platform, has announced the launch of ADME-Oneā¢, a...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
BOSTON, Massachusetts, May 26, 2026 Ginkgo Bioworks, through its Ginkgo Datapoints platform, has announced the launch of ADME-Oneā¢, a...
